|
Co-Founder and Chairman of the Board, is a board certified internist and has been practicing medicine for 30 years. He is a graduate of Harvard Medical School and completed his residency at New York Hospital . His clinical expertise is in the field of oncology. In 1991 Dr. Garren did a three-year postdoctoral fellowship in molecular biology at Stanford in Dr. Paul Berg's lab. During this period he researched the effects of the Nef gene from the HIV virus. An additional year was spent as a visiting scholar in the Biochemistry Dept. at Stanford. Dr. Garren continues to practice hospital-based oncology as well as consult for biotech companies in the San Francisco Bay area. He has a founder equity position in Rigel Pharmaceuticals, Inc., a public biotechnology company located in South San Francisco . Biotech Insight, an internet publication authored by Dr. Garren, provides insightful discussion of competing technologies and future advances. Dr. Garren also consults for three hedge funds that invest in biotech companies. | 